中国的，也是世界的；世界的，就是中国的。
中医药走向世界系列教材世界中医学专业核心课程教材（World Textbook Series for Chinese Medicine Core Curriculum）
世界中医学专业核心课程教材（World Textbook Series for Chinese Medicine Core Curriculum）丛书总主编为张伯礼院士和世界中医药学会联合会教育指导委员会。《中医儿科学》由马融教授和韩新民教授主编，国际知名中医专业英语翻译和英语语言专家联合翻译、编校。这是*套基于《世界中医学本科（CMD前）教育标准》的世界中医学专业核心课程教材，具有国际性、科学性、系统性、完整性、实用性。可供世界各国、地区中医教育机构接受中医学专业教育的海外学生，以及国内中医院校留学生使用，亦可为双语教学师生和广大中医爱好者学习提供参考。
世界中医学专业核心课程教材（13分册）
World Textbook Series for Chinese Medicine Core Curriculum（13 fascicles）
中医基础理论
Funda
总主编：
张伯礼，生于1948年，中国工程院院士，中医内科专家，全国名中医，国家重点学科中医内科学学科带头人。现任天津中医药大学校长，中国中医科学院名誉院长，国家重大新药专项技术副总师，国务院医改咨询专家委员会委员，教育部医学教育专家委员会副主任，中国药典委员会副主任委员，世界中医药学会联合会教育指导委员会会长。兼任中国中西医结合学会名誉会长、中华中医药学会副会长、中华医学会副会长、世界中医药学会联合会副主席。
几十年来，主要从事心脑血管疾病中西医结合防治和中医药现代化研究。开展血管性痴呆（VD）研究，制定了VD证类分型标准和按平台、波动及下滑三期证治方案；明确了中风病证候和先兆症动态演变规律，建立了综合治疗方案；创立了脑脊液药理学方法，揭示中药对神经细胞保护作用机制；完成了首例中药对冠心病二级预防大规模循证研究，建立了中医药循证评价系列方法。三次担任国家973计划项目首席科学家，提出效应配伍理论和以组分配伍研制现代中药的关键技术；开拓中成药二次开发研究领域，培育了中药大品种群；倡导中药智能制造推动了中药产业技术升级。总主编：
张伯礼，生于1948年，中国工程院院士，中医内科专家，全国名中医，国家重点学科中医内科学学科带头人。现任天津中医药大学校长，中国中医科学院名誉院长，国家重大新药专项技术副总师，国务院医改咨询专家委员会委员，教育部医学教育专家委员会副主任，中国药典委员会副主任委员，世界中医药学会联合会教育指导委员会会长。兼任中国中西医结合学会名誉会长、中华中医药学会副会长、中华医学会副会长、世界中医药学会联合会副主席。
几十年来，主要从事心脑血管疾病中西医结合防治和中医药现代化研究。开展血管性痴呆（VD）研究，制定了VD证类分型标准和按平台、波动及下滑三期证治方案；明确了中风病证候和先兆症动态演变规律，建立了综合治疗方案；创立了脑脊液药理学方法，揭示中药对神经细胞保护作用机制；完成了首例中药对冠心病二级预防大规模循证研究，建立了中医药循证评价系列方法。三次担任国家973计划项目首席科学家，提出效应配伍理论和以组分配伍研制现代中药的关键技术；开拓中成药二次开发研究领域，培育了中药大品种群；倡导中药智能制造推动了中药产业技术升级。
获得包括国家科学技术进步一等奖在内的国家奖7项，省部级科学技术进步一等奖10项，发表论文350余篇，出版专著30余部。培养毕业研究生约260余名。所指导的3篇博士论文获全国百篇优秀博士论文，2篇获全国百篇优秀博士论文提名荣誉。
学风严谨，富于创新，形成了采用现代科学技术研究中医药学的突出特色，取得一批重要成果，贡献突出，成绩卓著。1991年起享受国务院颁发的政府特殊津贴。被授予全国优秀共产党员（2011）、全国先进工作者（2005）、全国优秀科技工作者（2001）、国家ji有突出贡献中青年专家（1991）等荣誉称号，获何梁何利奖（2006）、吴阶平医学奖（2015）及中医药国际贡献奖（2010）等荣誉。
Dr. Zhang Bo-liis an academician and a China-renowned specialist and academic leader in Chinese internal medicine, a national key discipline recognized as important and receiving support by the Chinese government. He is currently the President of the Tianjin University of Traditional Chinese Medicine and the China Academy of Chinese Medical Sciences. He is also the Deputy Chief Engineer of the National Major Scientific and Technological Special Project for "Significant New Drugs Development", a member of the Medical Reform Advisory Committee of the State Council, Vice Committee Director of the Pharmacopoeia Committee, Director of the National Chinese Medicine Teaching Advisory Board of the Ministry of Education and Director of the Educational Instruction Committee of theWorld Federation of Chinese Medicine Societies. Moreover, he holds concurrent posts such as Honorary President of the China Association of Integrative Medicine, Vice President of the China Association of Traditional Chinese Medicine and Vice President of the World Federation of Chinese Medicine Societies.
For decades, Dr. Zhang has been devoted to the prevention and treatment of cardiovascular and cerebrovascular diseases by integrating traditional Chinese medicine with western medicine, and to the modernization of Chinese medicine CM. He carried out studies on vascular dementia VD and formulated the classification criteria for VD patterns and a treatment scheme based on three phases, i.e., stable, fluctuating and aggravated phases. He specified the patterns and manifestations of stroke as well as the dynamic progression of its premonitory symptoms, and developed a comprehensive therapeutic schedule. He created the pharmacological method of cerebrospinal fluid CSF and demonstrated the protective effect of Chinese medicinals on nerve cells and the relevant mechanisms. He completed the first large-scale evidence-based study on the secondary prevention of coronary heart disease with Chinese medicinals, and developed a series of methods for evidence-based evaluation on CM. He served as Chief Scientist of the National Program on Key Basic Research Project of China 973 Program for three consecutive terms and developed the theory of effect-based compatibility as well as the critical technology for the research and development of modern Chinese medicinals through component-based compatibility. He expanded the research field of the secondary development of Chinese patent medicine which introduced a large group of mass market medicines, and initiated the intelligent manufacturing of Chinese medicinals which promoted the technological upgrading of CM industry.
Dr. Zhang has won 7 national awards including the first prize for national progress in science and technology and 10 first-prize provincial and ministerial awards for progress in science and technology. He has published more than 350 papers and over 30 monographs or textbooks. He has mentored and cultivated more than 200 postgraduates.
Dr. Zhang is widely recognized for his prominent contributions in advancing CM. Since 1991, he has been granted a special government allowance by the State Council. He has been conferred with many honorary titles and awards, including National Advanced Worker 2005, Outstanding Scientific and Technological Worker 2001 and National Young and Middle-aged Expert with Outstanding Contribution 1991 as well as the Ho Leung Ho Lee Prize 2006, Wu Jie-ping Medical Research Award 2015 and International Award for Outstanding Contribution to Chinese Medicine 2010.
世界中医药学会联合会教育指导委员会简介
A Brief Introduction to the Educational Instruction Committee of the World Federation of Chinese Medicine Societies
The Educational Instruction Committee EIC of the World Federation of Chinese Medicine Societies WFCMS is an international advisory, decision-making, and guiding institution concerning Chinese Medicine CM education under WFCMS. It carries out important work and research on international CM education, consultancy and coordination, and its headquarters are located in Tianjin, P. R. China Tianjin University of Traditional Chinese Medicine. The secretariat is the standing office of EIC.
The purposes of the EIC are to increase understanding between international regions and CM educational institutions, to advocate exchanges and cooperation within CM educational communities, to improve the level of CM education, and to promote the CM education industry, in order to make a greater contribution to world CM personnel training.
The mission of the EIC is to generalize the standardization of international CM education; to promote and ensure a healthy and well-ordered development of CM education in various countriesregions according to the international industry standard of CM education released by WFCMS; and to convene international academic conferences, symposia and exhibitions.
The mission also is to set up a website on international CM education and provide consultancies and information services; to construct a platform of international exchanges and advocate the unique features and domination of various countriesregions; to strengthen exchanges and cooperation among CM educational institutions from different countriesregions; to publish academic articles on CM education and research; to study the rules and experiences about CM education in respective countriesregions, to encourage CM educational reform and innovations, and to study international CM education.
In order to improve CM education in the world, the EIC organizes international CM education training, teacher training, teacher exchanges, further education, and remote education. It actively cooperates with relevant departments of WFCMS in level examinations and qualification approvals.
EIC commits itself to promote international exchanges and development of CM education, to improve global CM personnel training, and to accelerate the spread and development of CM sciences in the world.
主编：
马融，医学博士、博士生导师、教授、主任医师。先后获得全国卫生系统先进工作者、国务院政府特殊津贴专家、天津市政府授衔中医小儿神经内科专家等称号。
購物車/收銀台(0) | 在線留言板
| 付款方式
| 聯絡我們
| 運費計算
| 幫助中心 |
加入書簽
HOME
新書上架
